Altern Ther Health Med. 2023 May;29(4):164-169.
Chronic renal failure (CRF) is the outcome of the continuous progression of various chronic kidney diseases. Effective treatment of a wide range of diseases may require decreasing patients' negative emotions and enhancing their disease resilience. Narrative care focuses on patients' inner awareness, feelings, and experience of a disease, stimulating positive energy in the face of it.
The study intended to investigate the effects of using narrative care during high flux hemodialysis (HFHD) on clinical outcomes and prognosis of quality of life (QoL) for patients with chronic renal failure (CRF), to provide a reliable theoretical reference for future clinical treatment.
The research team performed a randomized controlled trial.
The study took place at the Blood Purification Center at the Affiliated Hospital of Medical School at Ningbo University in Ningbo, Zhejiang, China.
Participants were 78 patients with CRF who received treat with HFHD at the hospital between January 2021 and August 2022.
The research team divided participants into two groups using the random number table method, with 39 participants in each group: (1) and intervention group who received narrative nursing care and (2) a control group who receive the usual care.
The research team: (1) evaluated the clinical efficacy for both groups; (2) at baseline and postintervention, measured participants' blood creatinine (SCr) and blood urea nitrogen (BUN) using blood sampling; (3) counted adverse effects; (4) investigated participants' nursing satisfaction postintervention; (5) at baseline and postintervention, assessed psychology and QoL using the Self-Assessment Scale for Anxiety (SAS), the Self-Assessment Scale for Depression (SDS), and the General Quality of Life Inventory (GQOLI-74) scale.
No statistically significant differences existed between the groups in terms of efficacy or renal function postintervention (P > .05). The incidence of adverse reactions was significantly lower in the intervention group than in the control group postintervention (P = .033), and the group's nursing satisfaction was significantly higher (P = .042). In addition, participants' SAS and SDS scores decreased significantly in the intervention group postintervention (P < .05), while no change occurred for the control group (P > .05). Finally, the GQOLI-74 scores were all significantly higher in the intervention group than in the control group.
Narrative care can effectively enhance the safety of HFHD treatment in CRF patients and reduce patients' negative emotions postintervention, which is important for improving their QoL.
慢性肾衰竭（CRF）是各种慢性肾脏病持续进展的结果。有效治疗广泛的疾病可能需要降低患者的负面情绪，增强他们对疾病的适应能力。叙事护理关注患者对疾病的内在意识、感受和体验，激发他们面对疾病的积极能量。
本研究旨在探讨在高通量血液透析（HFHD）过程中使用叙事护理对慢性肾衰竭（CRF）患者临床结局和生活质量（QoL）预后的影响，为未来临床治疗提供可靠的理论参考。
研究团队进行了一项随机对照试验。
研究地点位于中国浙江宁波大学医学院附属医院血液净化中心。
参与者为 2021 年 1 月至 2022 年 8 月在该医院接受 HFHD 治疗的 78 例 CRF 患者。
研究团队使用随机数字表法将参与者分为两组，每组 39 人：（1）干预组接受叙事护理，（2）对照组接受常规护理。
（1）评估两组的临床疗效；（2）在基线和干预后，通过采血评估参与者的血肌酐（SCr）和血尿素氮（BUN）；（3）计算不良反应发生率；（4）在干预后评估参与者的护理满意度；（5）在基线和干预后，使用焦虑自评量表（SAS）、抑郁自评量表（SDS）和一般生活质量量表（GQOLI-74）评估参与者的心理和生活质量。
干预后两组在疗效或肾功能方面无统计学差异（P >.05）。干预组不良反应发生率明显低于对照组（P =.033），护理满意度明显高于对照组（P =.042）。此外，干预组 SAS 和 SDS 评分在干预后明显下降（P <.05），而对照组无变化（P >.05）。最后，干预组的 GQOLI-74 评分明显高于对照组。
叙事护理可有效提高 CRF 患者 HFHD 治疗的安全性，降低患者干预后的负面情绪，对提高其生活质量具有重要意义。
